Valuation: Cegedim

Market Cap 144M 166M 134M 123M 233M 15.76B 236M 1.58B 618M 7.88B 622M 609M 26.11B P/E 2026 *
6.87x
P/E 2027 * 5.24x
Enterprise Value 306M 352M 285M 262M 496M 33.53B 501M 3.36B 1.32B 16.76B 1.32B 1.29B 55.53B EV / Sales 2026 *
0.46x
EV / Sales 2027 * 0.41x
Free-Float
36.52%
Yield 2026 *
-
Yield 2027 * -
1 day-14.07%
1 week+19.82%
Current month+19.35%
1 month+15.28%
3 months+1.25%
6 months-8.65%
Current year-9.33%
1 week 10.18
Extreme 10.18
12.15
1 month 10.12
Extreme 10.12
12.15
Current year 8.6
Extreme 8.6
14.8
1 year 8.6
Extreme 8.6
14.8
3 years 8.6
Extreme 8.6
21.2
5 years 8.6
Extreme 8.6
29
10 years 8.6
Extreme 8.6
42.5
Manager TitleAgeSince
Chief Executive Officer 83 2009-10-24
Director of Finance/CFO - 2016-06-13
Corporate Officer/Principal 55 2015-11-25
Director TitleAgeSince
Chairman 83 2009-10-24
Director/Board Member 72 2010-08-08
Director/Board Member 55 2009-10-25
Change 5-day change 1-year change 3-year change Capi.($)
-14.07%+19.82% - - 166M
-0.89%+22.98%-43.36%+24.72% 420B
+2.15%+5.37%-30.78%+39.02% 222B
+0.18%+2.10%-34.71%+6.50% 122B
-1.24%+2.35%-33.41%+17.94% 48.59B
-0.30%+5.94%-73.67%+166.63% 37.52B
+4.53%-20.87%-19.11%+26.15% 22.61B
+5.00%+8.77%-25.68%+74.08% 19.6B
-0.84%+1.82%-28.30%+7.68% 13.94B
+0.42%-4.42%-28.33%+88.26% 13.35B
Average -0.47%+3.07%-35.26%+50.11% 102.23B
Weighted average by Cap. +0.34%+11.98%-38.46%+32.94%

Financials

2026 *2027 *
Net sales 660M 760M 615M 565M 1.07B 72.25B 1.08B 7.25B 2.83B 36.12B 2.85B 2.79B 120B 684M 788M 638M 586M 1.11B 74.94B 1.12B 7.52B 2.94B 37.46B 2.96B 2.89B 124B
Net income 21.3M 24.53M 19.86M 18.24M 34.5M 2.33B 34.88M 234M 91.53M 1.17B 92.12M 90.1M 3.86B 28M 32.25M 26.11M 23.98M 45.36M 3.07B 45.86M 308M 120M 1.53B 121M 118M 5.08B
Net Debt 162M 187M 151M 139M 263M 17.76B 266M 1.78B 697M 8.88B 701M 686M 29.42B 134M 154M 125M 115M 217M 14.65B 219M 1.47B 575M 7.32B 578M 566M 24.27B
Logo Cegedim
Cegedim is a European leading in collecting, processing, and distributing data and services related to medical information. Net sales break down by market as follows: - Insurance companies and services (73.4%): computerization of insurers and mutual benefit insurance companies, management of third-party payers and health care trends, external human resources management, computer and Internet services, etc. The group also develops processing sales statistics of pharmaceutical products, management of medical samples and promotional materials activities, etc. (GERS); - Health care professionals (20.6%): software for physicians and pharmacists, pharmaceutical data base, scientific, medical, and promotional information, etc.; - other (6%). France accounts for 91.9% of net sales.
Employees
6,344
Date Price Change Volume
25-04-29 12.15 -56.91% 120
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
10.48EUR
Average target price
15.50EUR
Spread / Average Target
+47.90%

Quarterly revenue - Rate of surprise